Correlation Between Cymbria and Cipher Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cymbria and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cymbria and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cymbria and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Cymbria and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cymbria with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cymbria and Cipher Pharmaceuticals.
Diversification Opportunities for Cymbria and Cipher Pharmaceuticals
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cymbria and Cipher is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Cymbria and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Cymbria is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cymbria are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Cymbria i.e., Cymbria and Cipher Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cymbria and Cipher Pharmaceuticals
Assuming the 90 days trading horizon Cymbria is expected to generate 2.88 times less return on investment than Cipher Pharmaceuticals. But when comparing it to its historical volatility, Cymbria is 3.84 times less risky than Cipher Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,504 in Cipher Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 31.00 from holding Cipher Pharmaceuticals or generate 2.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cymbria vs. Cipher Pharmaceuticals
Performance |
| Timeline |
| Cymbria |
| Cipher Pharmaceuticals |
Cymbria and Cipher Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cymbria and Cipher Pharmaceuticals
The main advantage of trading using opposite Cymbria and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cymbria position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.| Cymbria vs. Clairvest Group | Cymbria vs. Uniteds Limited | Cymbria vs. E L Financial Corp | Cymbria vs. Senvest Capital |
| Cipher Pharmaceuticals vs. Knight Therapeutics | Cipher Pharmaceuticals vs. Biosyent | Cipher Pharmaceuticals vs. Aptose Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |